Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.

Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Technology used to tag friends on social media could change the way drug discovery is done.

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.

Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.

Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.

Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.